Regulatory News:

Amplitude Surgical (Paris:AMPLI) (ISIN: FR0012789667, Ticker: AMPLI, PEA-PME eligible), a leading French player on the global surgical technology market for lower-limb orthopedics, today updates its 2018-19 financial information calendar.

Event   Dates *   New dates*
2018-19 Q1 Sales   Thursday November 22, 2018   Friday February 1, 2019
2018-19 H1 Sales   Thursday February 21, 2019   -
2018-19 H1 Results   Wednesday March 27, 2019   -
2018-19 Q3 Sales   Thursday April 25, 2019   -
2018-19 Full-Year Sales   Thursday July 25, 2019   -
2018-19 Full-Year Results   Wednesday October 23, 2019   -
2019-20 Q1 Sales   Thursday November 21, 2019   -

* Subject to modification. Press releases are published after market closes.

Next financial press release: S1 2018-19 sales, on Friday February 1, 2019, after market.

About Amplitude Surgical

Founded in 1997 in Valence, France, Amplitude Surgical is a leading French player on the global surgical technology market for lower-limb orthopedics. Amplitude Surgical develops and markets high-end products for orthopedic surgery covering the main disorders affecting the hip, knee and extremities, and notably foot and ankle surgery. Amplitude Surgical develops, in close collaboration with surgeons, numerous high value-added innovations in order to best meet the needs of patients, surgeons and healthcare facilities. A leading player in France, Amplitude Surgical is developing abroad through its subsidiaries and a network of exclusive distributors and agents distributing its products in more than 30 countries. Amplitude Surgical operates on the lower-limb market through the intermediary of its Novastep subsidiaries in France and the United States. At June 30, 2018, Amplitude Surgical had a workforce of 428 employees and recorded sales of over 100 million euros.